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Risk Factors for Rehospitalization for Acute Coronary Syndromes and
Unplanned Revascularization Following Acute Myocardial Infarction
Suzanne V. Arnold, MHA, MD; Kim G. Smolderen, PhD; Kevin F. Kennedy, MS; Yan Li, PhD; Supriya Shore, MD; Joshua M. Stolker, MD;
Tracy Y. Wang, MSc, MHS, MD; Philip G. Jones, MS; Zhenxiang Zhao, PhD; John A. Spertus, MPH, MD
Background-—Rehospitalizations for acute coronary syndromes (ACS) and coronary revascularization after an acute myocardial
infarction (AMI) are not only common and costly but can also impact patients’ quality of life. In contrast to mortality and all-cause
readmissions, little insight is available into risk factors associated with ACS and revascularization after AMI.
Methods and Results-—In a multicenter AMI registry, we examined the rates and predictors of rehospitalizations for ACS and
revascularization within the year after AMI among 3283 patients. Staged revascularization procedures were excluded. Kaplan–
Meier estimated rates of rehospitalization due to ACS and revascularization were 6.8% and 4.1%, respectively. In hierarchical,
multivariable models, the strongest predictors of rehospitalization for ACS were coronary artery bypass graft prior to AMI
hospitalization (hazard ratio [HR] 2.12, 95% CI 1.45 to 3.10), female sex (HR 1.67, 95% CI 1.23 to 2.25), and in-hospital PCI (HR
1.85, 95% CI 1.28 to 2.69). The strongest predictors of subsequent revascularization were multivessel disease (HR 2.89, 95% CI
1.90 to 4.39) and in-hospital percutaneous coronary intervention with a bare metal stent (HR 2.08, 95% CI 1.19 to 3.63). The
Global Registry of Acute Coronary Events mortality risk score was not associated with the risk of rehospitalization for ACS or
revascularization.
Conclusions-—Unique characteristics are associated with admissions for ACS and revascularization, as compared with survival.
These multivariable risk predictors may help identify patients at high risk for ACS and revascularization, in whom intensification of
secondary prevention therapies or closer post-AMI follow-up may be warranted. ( J Am Heart Assoc. 2015;4:e001352 doi:
10.1161/JAHA.114.001352)
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W hile the mortality associated with an acute myocardialinfarction (AMI) has been steadily declining,1 this
trend has been accompanied by a growing need to better
manage patients’ postdischarge and chronic care after an
AMI. In particular, rehospitalizations for acute coronary
syndromes (ACS) and coronary revascularization continue to
occur commonly after an AMI,2 impacting patients’ quality of
life and increasing healthcare costs. Although several risk
models have identified clinical factors associated with higher
risk of mortality,3,4 all-cause rehospitalization,5 or a variety of
composite clinical end points,6 there are no studies, which we
are aware of, to describe the risk factors associated
specifically with ACS rehospitalization or coronary revascu-
larization after AMI. Analyses examining predictors of com-
posite events, such as major adverse cardiac events, are
reasonable if the individual end points of that composite have
similar predictors. However, if the risk factors for different
facets of the combined outcome are different, then different
interventions may be necessary to prevent their occurrence.
As such, more insight into the risk factors for ACS and
coronary revascularization is needed (in particular, if these
vary from the risk factors for mortality after AMI).
To address this gap in knowledge, we examined patients
from a prospective multicenter registry of AMI patients in
whom validated hospitalizations for ACS and coronary revas-
cularization procedures over the year after discharge were
collected. These analyses could lay the foundation for better
transitional care in high-risk patients and help identify a
cohort of patients at high risk for ACS or revascularization to
be studied in future clinical trials seeking to improve these
outcomes.
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Methods
Study Population and Protocol
The study design, patient selection, site characteristics, and
follow-up assessments of the Translational Research Investi-
gating Underlying disparities in acute Myocardial infarction
Patients’ Health status (TRIUMPH) study have been previously
published.7 Briefly, consecutive patients with AMI admitted to
24 US hospitals were screened for enrollment into the
TRIUMPH registry between April 2005 and December 2008.
Eligible patients were required to have biomarker evidence of
myocardial necrosis and additional clinical evidence support-
ing the diagnosis of an AMI, including ischemic signs/
symptoms or electrocardiographic ST changes during the
initial 24 hours of admission. Eligible patients were also
required to either initially present to an enrolling institution or
be transferred to that hospital within 24 hours of presentation.
Baseline sociodemographic and clinical data were obtained
through chart abstraction and a detailed structured interview
within 24 to 72 hours after admission. As part of study
enrollment, patients were asked to provide permission for
TRIUMPH study personnel to obtain and adjudicate medical
records from any subsequent hospitalizations that took place
in the year following their AMI. Only patients who provided
consent for medical record collection were included in these
analyses. Each participating hospital obtained Institutional
Research Board approval, and all patients provided written
informed consent.
Rehospitalization Data
Detailed follow-up interviews were attempted on all survivors
at 1, 6, and 12 months after AMI. All patients were asked to
report interval events (eg, procedures, diagnostic tests,
hospitalizations, and outpatient visits) since their last study
contact. If a patient reported being hospitalized since the
previous interview, records of that hospitalization were
obtained to adjudicate cardiovascular events, including ACS
(ie, ST-elevation and non-ST-elevation AMI and unstable
angina [UA]) and revascularization procedures. Rehospitaliza-
tion for AMI was defined in the same manner as per the
incident event in TRIUMPH, as described above. UA was
defined, per guidelines, as a hospitalization due to symptoms
suggestive of ischemia that occurred at rest, was of new
onset, or was increasing in severity (ie, more frequent, longer
in duration, or lower in threshold).8 Revascularization proce-
dures included percutaneous coronary interventions (PCI) and
coronary artery bypass graft (CABG) surgeries that were
performed for elective, urgent, or emergent indications over
the year following AMI. To assure we were not just examining
predictors of recurrent AMI, revascularizations in the setting
of a repeat AMI were excluded. In addition, to exclude
revascularizations that were planned during the index AMI,
staged PCI (determined through adjudication) and elective
CABGs within the 4 weeks of AMI hospitalization were
excluded. Chart abstractions were sent to 2 cardiologists
who independently classified the reason for hospitalization. If
there was disagreement between the 2 cardiologists, the
record was adjudicated by a third senior cardiologist and, if
disagreement persisted, up to 5 cardiologists independently
reviewed the charts until consensus was obtained. To ensure
the validity of the ACS and revascularization hospitalizations,
patients who reported hospitalizations for which their data
were not available for adjudication were excluded.
Statistical Analysis
We first examined the unadjusted incidence of ACS and
revascularization hospitalizations with Kaplan–Meier curves.
To examine for potential biases due to attrition from mortality,
we considered death as a competing event to compare the
cumulative incidence rates with the Kaplan–Meier estimated
rate of rehospitalization. We then constructed a series of
multivariable Cox regression models (1) to identify whether
the predictors of mortality differed from the predictors of ACS
and revascularization hospitalizations; and (2) to identify
specific predictors of ACS and revascularization. All models
were adjusted for site using stratified proportional hazards
models that allowed for site-specific baseline hazards.
To examine whether the predictors of mortality differed
from the predictors of ACS and revascularization hospitaliza-
tions, we first constructed 2 models including only the Global
Registry of Acute Coronary Events (GRACE) score,3 which
incorporates several prognostically important factors includ-
ing age, creatinine, heart failure, and in-hospital revascular-
ization procedures. Next, we constructed separate
multivariable Cox regression models to (1) identify the
predictors of ACS and (2) identify the predictors of revascu-
larization. Candidate covariates for the model were selected a
priori, based on clinical judgment, and included age, female
sex, white race, self-reported avoidance of care due to cost,
lack of medical insurance, currently working, prior MI, prior
PCI, prior CABG, prior heart failure, diabetes mellitus, prior
stroke or transient ischemic attack, peripheral artery disease,
depression, multivessel disease (2 or more epicardial stenos-
es ≥70% or left main stenosis ≥50%), ST-elevation AMI (versus
non-ST-elevation), discharge heart rate, discharge systolic
blood pressure, serum creatinine, in-hospital PCI, in-hospital
CABG, and quality-of-care indicators (defined as receiving all
quality-of-care eligible treatments during AMI [aspirin and
b-blocker within 24 hours; aspirin, b-blocker, and angiotensin-
converting enzyme/angiotensin II receptor blocker at dis-
charge; smoking cessation instructions; and timely reperfusion
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for ST-elevation AMI]). For in-hospital PCI, we tested whether
there was any significant difference between type of stent
(drug-eluting stent versus bare metal stent or balloon
angioplasty only), and if this was significant, included stent
type in the model.
Harrell’s backward selection strategy was used to identify
factors significantly associated with UA and revascularization.9
Each covariate was ranked by its contribution to the multivar-
iable model (as assessed by F-value), and the variables with the
smallest contribution to the model were sequentially elimi-
nated until further variable elimination led to a >10% loss in
model prediction, as compared with the initial model. The
remaining covariates comprised the final parsimonious model
and explained >90% of the variance of the full model. As an
additional analysis, this approach was repeated with UA alone
as the ACS outcome of interest, given its common inclusion as
a component of major adverse cardiac events and the absence
of any existing model specifically focusing on this outcome.
Baseline data were complete, with 7% of patients missing 1
baseline data item, 0.1% missing 2 items, and a mean number
of missing items per patient of 0.08. Missing data were
imputed with 5 imputation data sets using IVEware (Imputa-
tion and Variance Estimation Software; University of Michi-
gan’s Survey Research Center, Institute for Social Research,
Ann Arbor, MI). All analyses were conducted using SAS v9.3
(SAS Institute, Inc, Cary, NC), and statistical significance was
determined by a 2-sided P<0.05.
Results
Patient Population
Among 4340 patients with AMI enrolled in TRIUMPH, 71 died
within the first month and never had the opportunity for
follow-up. Of the 4269 patients eligible for follow-up, 637
(14.9%) patients were lost to follow-up and an additional 349
(8.2%) were excluded as they reported hospitalizations for
which the records were unavailable for adjudication, either
because the patient did not consent to a medical records
release (n=77) or the admitting hospital refused to honor the
medical records release (n=272). The final analytic cohort
comprised the remaining 3283 patients (Figure 1). Excluded
patients were more likely to be younger, nonwhite, conser-
vatively managed during the index hospitalization, and to have
more extensive baseline cardiovascular disease and risk
factors (Table 1). Overall, the mean age of the patients
included in the final analytic cohort was 59 years, one third
were female, 70% were white, and 45% presented with ST-
elevation AMI. Clinical characteristics were typical of patients
with AMI in contemporary studies, including 29% with
diabetes, 20% with prior AMI, and 25% with prior coronary
revascularization procedures.
Characteristics Associated With ACS
Rehospitalizations
The Kaplan–Meier estimated rate of rehospitalization due to
ACS was 6.8% (0.4% ST-elevation AMI, 1.6% non-ST-elevation
AMI, 5.0% UA; 49% of which were treated with revasculariza-
tion), with a mean time to event of 4.9 months after hospital
discharge. If we consider the competing risk of death, the
cumulative incidence rate of readmission for ACS remained
6.8%, indicating no significant bias due to attrition from
mortality (Figure 2A). In the model to determine whether the
predictors of death differed from those of ACS, GRACE score (a
score that estimates risk of long-term mortality after AMI) was
not associated with risk of ACS (per 10-point increase: hazard
ratio [HR] 0.96, 95% CI 0.92 to 1.01, P=0.17). In the
multivariable model, the most significant predictors of rehos-
pitalization for ACS (in terms of F-value) were CABG prior to
AMI hospitalization (HR 2.12, 95% CI 1.45 to 3.10), female sex
(HR 1.67, 95% CI 1.23 to 2.25), and in-hospital PCI (HR 1.85,
95% CI 1.28 to 2.69; Table 2). There was no significant
difference between stent types, in terms of risk of ACS
rehospitalization (P=0.10). Other significant predictors of ACS
rehospitalization were PCI prior to AMI hospitalization, younger
age, and if the patient was not currently working at the time of
their AMI. There were minimal differences when predicting an
admission of UA alone (versus the composite outcome of ACS)
in the year after AMI (Table 3).
Characteristics Associated With Coronary
Revascularization Hospitalizations
The Kaplan–Meier estimated rate of rehospitalization for
revascularization procedures that were not planned during the
AMI Patients 
N=4340 








Hospitalizations w/o adjudication 
N=349 
Figure 1. Flowchart of patients. AMI indicates acute myocardial
infarction.
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index AMI was 4.1% (48% of which were due to ACS), 89% of
which were PCIs with a mean time to event of 4.9 months. In
the competing risk analysis that included death, the cumu-
lative incidence rate of readmission for revascularization
remained 4.1%, indicating no significant bias due to attrition
from mortality (Figure 2B). GRACE score was not significantly
associated with risk for revascularization (per 10-point
increase: HR 0.95, 95% CI 0.89 to 1.02, P=0.132). In the
multivariable model, the most significant predictor of rehos-
pitalization for revascularization (in terms of F-value) was the
presence of multivessel disease, which was associated with a
nearly 3-fold increased hazard of revascularization in the year
following AMI (HR 2.89, 95% CI 1.90 to 4.39; Table 2). Other
significant predictors of revascularization were in-hospital PCI
and in-hospital CABG (the latter predicting a decreased risk of
revascularization). The type of stent received by the patient
was associated with the risk for repeat revascularization over
the year following AMI (P=0.011). In-hospital PCI with a bare
metal stent or angioplasty alone was associated with a 2.08
increased hazard of a subsequent revascularization rehospi-
talization (95% CI 1.19 to 3.63), while in-hospital PCI with a
drug-eluting stent was not associated with a significantly
increased hazard of repeat revascularization.
Discussion
In a large, prospective, multicenter US registry of patients
hospitalized for AMI, we found that 6.8% of patients were
rehospitalized for ACS and 4.1% are rehospitalized for
revascularization procedures over the first year following
AMI. Different risk factors were associated with these
different types of admissions. Those with a prior CABG,
female patients, those with prior or in-hospital PCI, and
patients not employed at the time of AMI were more likely to
be hospitalized for ACS, while patients with multivessel
disease and those who underwent PCI with a bare metal stent
Table 1. Baseline Characteristics of Patients Included in the








Age 59.412.0 57.513.2 <0.001
Female sex 32.7% 35.4% 0.109
White race 69.9% 59.2% <0.001
Married 53.4% 44.8% <0.001
High school education 79.9% 77.8% 0.159
No medical insurance 19.3% 25.0% <0.001
Currently working 50.6% 45.1% 0.003
Medical history
Dyslipidemia 49.4% 48.0% 0.429
Hypertension 66.1% 67.7% 0.336
Prior stroke/TIA 6.7% 7.7% 0.275
Peripheral vascular disease 4.7% 4.6% 0.899
Diabetes mellitus 29.0% 35.8% <0.001
Prior myocardial infarction 19.6% 24.8% <0.001




Chronic kidney disease 6.3% 10.4% <0.001
Chronic lung disease 7.0% 7.8% 0.392
Chronic heart failure 6.9% 13.6% <0.001
Current smoker 38.4% 43.2% 0.007
Body mass index, kg/m2 29.66.5 29.56.5 0.64
Acute presentation






Unknown (no angiogram) 6.2% 11.8%
ST-elevations 44.6% 37.6% <0.001
Troponin peak, ng/dL 29.375.6 25.761.4 0.174








Aspirin at discharge* 95.0% 92.3% 0.001



















ACE indicates angiotensin-converting enzyme; ARB, angiotensin II receptor blocker;
GRACE, Global Registry of Acute Coronary Events; TIA, transient ischemic attack.
*Among patients who were eligible for treatments (eg, ACE inhibitor/ARB among those
with ventricular dysfunction; smoking cessation counseling among current smokers, etc.).
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were more likely to be hospitalized for revascularization.
Patients’ mortality risks, as measured with the GRACE
mortality risk score, were not associated with the risk of
either an ACS or a revascularization rehospitalization. These
findings demonstrate that the predictors for rehospitalization
for ACS and revascularization, which likely relate more to
recurrence or progression of the underlying coronary disease,
are different from those of mortality. Given the potential
impact on patients’ quality of life and healthcare costs,
targeted strategies are needed to reduce these events.
Many prior studies have investigated the frequency and
predictors of death after AMI3,4 or composites of major
adverse cardiac events (which include death).6 However, as
mortality rates decline, additional focus is needed on other
nonfatal outcomes such as rehospitalizations, procedures,



































































Figure 2. Kaplan–Meier curves of cumulative incidence of rehospitalization due to (A) acute coronary
syndromes (ACS) and (B) revascularization, with the competing risk of death.
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coronary events not only consume healthcare resources,11
but also they can be stressful to patients and may adversely
affect their quality of life.12 Understanding the predictors of
these adverse events is important in order to create strategies
of care to try to mitigate these hospitalizations. While some
patient characteristics were differentially associated with the
2 events, many of the most important predictors that we
identified related to the overall burden of cardiovascular
disease, emphasizing the importance of aggressive secondary
prevention efforts in high-risk patients. Other characteristics
associated with the outcomes, beyond risk factors for
atherosclerotic disease, are more challenging to explain. For
example, younger age and female sex would not be expected
to be associated with greater cardiovascular disease progres-
sion, and yet are strongly associated with subsequent ACS
admission, but less so with revascularization. This is congruent
with prior studies that have shown that both female sex and
younger age are associated with more angina13 and worse
disease-specific quality of life10 after an AMI, which may
explain their association with ACS admissions, mostly in the
absence of need for revascularization (ie, medically managed).
Our finding that the predictors of ACS and revasculariza-
tion rehospitalizations were disparate from those of mortality
highlights the need to examine events individually, rather than
as composite end points. Most prior studies that have
explored the impact of recurrent hospitalizations after an AMI
have focused on the first 30 days.14–16 This time frame has
been of particular interest as 30-day readmission has been
put forth as a quality metric, is publicly reported, and has
reimbursement implications for hospitals.17 In one of these
studies, the rate of all-cause readmission was 18.6% in the
30 days after AMI, and the rate of unplanned revasculariza-
tion was 2.3%.14 While this prior study did not evaluate
predictors of revascularization, patients who were medically
managed or who had complications from invasive procedures
were more likely to require rehospitalization in the 30 days
after AMI.
In another study looking at readmissions after AMI, the
rate of all-cause readmission was 14.5% in the United States
within the first 30 days after an ST-elevation AMI, with
multivessel disease being the strongest predictor of a
readmission.15 While all-cause readmissions are common
and ought to be avoided, many of the reasons for such
admissions are distinct from patients’ cardiovascular disease,
as only 43% of rehospitalizations during the first 30 days were
Table 2. Factors Associated With Rehospitalization for Acute Coronary Syndrome and Revascularization
Predictor (Ordered by F-Value)
Acute Coronary Syndrome
Predictor (Ordered by F-Value)
Revascularization
HR (95% CI) F-Value P Value HR (95% CI) F Value P Value
Prior CABG 2.12 (1.45 to 3.10) 14.7 <0.001 Multivessel disease 2.89 (1.90 to 4.39) 24.7 <0.001
Female sex 1.67 (1.23 to 2.25) 11.2 0.001 In-hospital PCI (BMS) 2.08 (1.19 to 3.63) 6.5 0.011
In-hospital PCI 1.85 (1.28 to 2.69) 10.7 0.001 In-hospital PCI (DES) 1.42 (0.81 to 2.48) 1.5 0.318
Prior PCI 1.63 (1.17 to 2.25) 8.5 0.004 In-hospital CABG 0.22 (0.07 to 0.73) 6.1 0.013
Age 0.98 (0.97 to 0.99) 8.4 0.004 Prior AMI 0.60 (0.34 to 1.05) 3.2 0.074
Currently working 0.69 (0.50 to 0.96) 4.9 0.027 Prior PCI 1.48 (0.90 to 2.44) 2.4 0.121
Peripheral artery disease 1.66 (0.98 to 2.80) 3.6 0.057 Female sex 1.28 (0.86 to 1.90) 1.4 0.229
No medical insurance 1.42 (0.97 to 2.10) 3.2 0.073 Prior heart failure 0.68 (0.27 to 1.73) 0.6 0.422
Diabetes mellitus 1.30 (0.95 to 1.75) 2.8 0.096 Currently working 0.87 (0.59 to 1.28) 0.5 0.483
In-hospital CABG 0.85 (0.44 to 1.65) 0.2 0.642
C-statistic for acute coronary syndrome model=0.662; for revascularization mode=0.687. AMI indicates acute myocardial infarction; BMS, bare metal stent; CABG, coronary artery bypass
graft surgery; DES, drug-eluting stent; HR, hazard ratio; PCI, percutaneous coronary intervention.
Table 3. Factors Associated With Rehospitalization for
Unstable Angina
Predictor (Ordered by F Value)
Unstable Angina
HR (95% CI) F-Value P Value
In-hospital PCI 2.34 (1.48 to 3.71) 13.0 <0.001
Female sex 1.83 (1.30 to 2.59) 11.7 0.001
Prior CABG 2.01 (1.27 to 3.19) 9.0 0.003
Age 0.98 (0.96 to 1.00) 6.4 0.012
Prior PCI 1.65 (1.12 to 2.44) 6.4 0.011
No medical insurance 1.71 (1.11 to 2.64) 5.8 0.016
Peripheral artery disease 1.76 (0.94 to 3.25) 3.2 0.075
Systolic BP (at discharge) 0.99 (0.98 to 1.00) 2.6 0.104
Diabetes mellitus 1.34 (0.94 to 1.92) 2.6 0.108
Currently working 0.74 (0.51 to 1.08) 2.4 0.118
In-hospital CABG 0.59 (0.23 to 1.52) 1.2 0.280
CABG indicates coronary artery bypass graft surgery; BP, blood pressure; HR, hazard
ratio; PCI, percutaneous coronary intervention.
DOI: 10.1161/JAHA.114.001352 Journal of the American Heart Association 6
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related to the index AMI in 1 study.14 In contrast to describing
all-cause readmissions, we focused on progression of coro-
nary disease to capture progression of the underlying
pathophysiological process that led to the initial AMI admis-
sion, which is why the observed rates in this study are so
much lower than these previous reports. By evaluating ACS
and revascularization hospitalizations in isolation, we sought
to identify patients at higher risk for progression of their
coronary disease, which may in turn encourage more
aggressive secondary prevention or monitoring in such
patients.
Furthermore, while these 30-day studies are clearly
important for hospital quality improvement, readmissions
beyond this short time frame also impact both patients and
the healthcare system, especially as accountable care orga-
nizations become more common. As traditional risk factors
for mortality are not associated with a greater likelihood of
rehospitalization for ACS or revascularization, treatments
known to reduce mortality may not be as effective in reducing
these rehospitalizations. Novel therapeutic strategies, such as
aggressive antianginal medications at discharge or early
postdischarge outpatient follow-up visits, likely need to be
developed and tested to reduce ACS and revascularization
admissions after an AMI. Furthermore, while these hospital-
izations are clearly an inconvenience to patients and consume
healthcare resources, the long-term implications of recurrent
angina and revascularization, in terms of mortality and quality
of life, are unknown and require further study.
There are a number of potential limitations to our study
that merit discussion. First, we relied on patient reporting of
hospitalization events to request records for adjudication. Due
to both patient under-reporting and loss to follow-up, we may
have underestimated the absolute rates of readmission.
Nevertheless, being able to carefully adjudicate hospital
admissions is a great strength of this study over using
administrative codes for “chest pain” hospitalizations without
further delineation into noncardiac chest pain, stable angina,
or UA—particularly given the known limitations of using
administrative data for clinical diagnoses.18 Second, due to
the relatively small number of events, we were limited in our
ability to investigate various demographic and clinical predic-
tors of rehospitalization. While we did examine a wide range of
demographic, socioeconomic, clinical, and treatment factors,
there may be other factors that are prognostically important
for ACS and revascularization hospitalizations that we did not
consider or that were not collected in the TRIUMPH study.
Future work to confirm the predictors identified here and to
evaluate novel predictors of ACS and revascularization would
be informative. Third, TRIUMPH was conducted when first-
generation drug-eluting stents were used. How newer-gener-
ation stenting would affect rehospitalizations is not known,
but as drug-eluting stents were not significantly associated
with rehospitalizations for revascularizations, even in TRI-
UMPH, the results would be unlikely to be materially altered
by use of newer stents. Finally, we have not described the
impact of these hospitalizations in terms of future mortality
and quality of life, and understanding the clinical importance
of these hospitalizations is important.
In conclusion, we found that 7% of patients are
rehospitalized for ACS and 4% are rehospitalized for
revascularization procedures over the first year following
AMI. The predictors for ACS and revascularization were
distinct from those for mortality, as quantified by the GRACE
score. As such, treatments known to reduce mortality may
not be the best targets for reducing these rehospitalizations.
Given the potential impact on patients’ quality of life and
healthcare costs, novel therapeutic strategies are needed to
reduce both the frequency and adverse impact of these
hospitalizations in the post-AMI period.
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